A detailed history of Lazard Asset Management LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 32,658 shares of CDNA stock, worth $699,534. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,658
Holding current value
$699,534
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$14.41 - $33.99 $470,601 - $1.11 Million
32,658 New
32,658 $1.02 Million
Q1 2023

May 15, 2023

BUY
$8.83 - $17.61 $5,130 - $10,231
581 Added 40.01%
2,033 $18,000
Q4 2022

Feb 14, 2023

SELL
$10.88 - $20.05 $68,391 - $126,034
-6,286 Reduced 81.24%
1,452 $16,000
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $39,314 - $64,602
2,448 Added 46.28%
7,738 $131,000
Q2 2022

Aug 09, 2022

BUY
$20.49 - $39.72 $42,311 - $82,021
2,065 Added 64.03%
5,290 $113,000
Q1 2022

May 13, 2022

BUY
$28.19 - $46.6 $22,044 - $36,441
782 Added 32.01%
3,225 $119,000
Q4 2021

Feb 09, 2022

BUY
$41.2 - $73.6 $164 - $294
4 Added 0.16%
2,443 $111,000
Q3 2021

Nov 15, 2021

SELL
$59.15 - $91.99 $9,464 - $14,718
-160 Reduced 6.16%
2,439 $154,000
Q2 2021

Aug 12, 2021

SELL
$63.02 - $95.11 $1,197 - $1,807
-19 Reduced 0.73%
2,599 $237,000
Q1 2021

May 14, 2021

SELL
$57.62 - $95.6 $24,834 - $41,203
-431 Reduced 14.14%
2,618 $178,000
Q4 2020

Feb 11, 2021

SELL
$41.43 - $77.09 $54,149 - $100,756
-1,307 Reduced 30.0%
3,049 $220,000
Q3 2020

Nov 13, 2020

SELL
$30.88 - $37.94 $25,290 - $31,072
-819 Reduced 15.83%
4,356 $165,000
Q2 2020

Aug 13, 2020

SELL
$18.95 - $35.43 $49,251 - $92,082
-2,599 Reduced 33.43%
5,175 $183,000
Q1 2020

May 14, 2020

BUY
$13.94 - $28.25 $61,419 - $124,469
4,406 Added 130.82%
7,774 $169,000
Q4 2019

Feb 13, 2020

BUY
$19.24 - $28.41 $37,999 - $56,109
1,975 Added 141.78%
3,368 $72,000
Q3 2019

Nov 14, 2019

BUY
$20.03 - $40.08 $27,901 - $55,831
1,393 New
1,393 $31,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.